Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | GSR | P00390 | 1/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.44 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30671932 | 0.99 | GSR (0.50) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL29706366 | 0.96 | GSR (0.50) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL30361562 | 0.94 | FOLH1 (0.47) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL30705346 | 0.94 | FOLH1 (0.49) | FOLH1GSRCPB2SLC15A2ACE | |
| SCHEMBL16770238 | 0.94 | GSR (0.51) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL29963837 | 0.94 | GSR (0.51) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL29963691 | 0.93 | FOLH1 (0.50) | FOLH1GSRCPB2SLC15A2ACE | |
| SCHEMBL31665994 | 0.93 | GSR (0.56) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL31666029 | 0.93 | GSR (0.56) | FOLH1GSRCPB2DPP8DPP9 | |
| SCHEMBL14490697 | 0.93 | GSR (0.56) | FOLH1GSRCPB2DPP8DPP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023004364-A2 | SELF-ASSEMBLING NANOMATERIAL FOR THE DETECTION, IMAGING, OR TREATMENT OF CANCER | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2023-01-26 | — | — | WO | disclosed |